Wednesday, May 15, 2024
Advertisement

NHS reform back on the agenda

IHPN CEO David Hare examines what the new White Paper proposals mean for the independent healthcare sector   It’s been two years since NHS England first published...

Mediscan still ‘inadequate’ say CQC inspectors

Mediscan Diagnostic Services has been told it must make further improvements to the quality of services following an unannounced inspection by the CQC. The...

Rutherford Cancer Centre collaborates with Nuffield Health

The Rutherford Cancer Centre North East has partnered with Nuffield Health Newcastle Hospital to launch a new oncology pathway which reduces exposure to radiation...

Strong growth at The Christie

The Christie Clinic LLP has reported a 10% jump in revenue to £43.5m as patient admissions and outpatient visits to the specialist oncology provider...

Spire committed to new strategy despite setbacks in H1

Spire Healthcare said today (18 September) that it remains committed to its five-year plan of achieving significant increases in self-pay and EBITDA, despite suffering...

Study reveals huge regional variation in access to NHS treatment

The NHS in England is treating significantly fewer patients than before the Covid-19 pandemic, according to a new study published by the Medical Technology...

Ramsay Health Care and Ascension in joint buying venture

Ramsay Health Care has entered into a joint venture with US healthcare group Ascension to build a new global supply chain. Ascension, the largest non-profit...

HM meets Martin Robb

UK hospital real estate has been attracting increased interest from new investors in recent years and the newest – Canadian NorthWest Healthcare Properties REIT...

St Andrew’s plans to sell Nottinghamshire hospital to NHS trust

Mental health provider St Andrew’s Healthcare (STAH) is in talks to sell its Mansfield hospital to Nottinghamshire Healthcare NHS Foundation Trust. The charity, which reported...

MHRA approves London-based psychedelic drug trial

The Medicines and Healthcare products Regulatory Authority has approved a new clinical trial to test whether psychedelic drugs can treat major depressive disorder. A novel...